43Z.F Schrödinger, Inc.
- Market cap
- EUR 2.14B
- P/E
- -
- P/B
- 7.17x
- ROE
- -40.5%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 43Z.F undervalued?
Graham numberThe Graham number of Schrödinger, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Schrödinger, Inc. fundamental analysis
No fundamental analysis for Schrödinger, Inc. yet.
Schrödinger, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug D…
Full company profileSchrödinger, Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Schrödinger, Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 138M | 181M | 217M | 208M | 256M | 243M |
| Gross Profit | 65.6M | 101M | 141M | 132M | 143M | 134M |
| Operating Income | -111M | -147M | -177M | -209M | -167M | -155M |
| EBITDA | - | -142M | -172M | -203M | -161M | -149M |
| Net Income | -100M | -149M | 40.7M | -187M | -103M | -122M |
| EPS | -1.41 | -2.09 | 0.56 | -2.57 | -1.40 | -1.64 |
| Balance Sheet | ||||||
| Total Assets | 756M | 689M | 803M | 823M | 726M | 612M |
| Total Liabilities | 199M | 241M | 254M | 402M | 362M | 310M |
| Shareholders' Equity | 557M | 448M | 549M | 421M | 364M | 302M |
| Cash & Short-term Investments | 120M | 90.5M | 155M | 147M | 231M | 247M |
| Cash Flow | ||||||
| Operating Cash Flow | -70.7M | -120M | -137M | -157M | 13.9M | -129M |
| Capital Expenditure | 7.17M | 8.01M | 13.4M | 7.31M | 1.44M | 5.54M |
| Free Cash Flow | -77.8M | -128M | -150M | -165M | 12.5M | -134M |
| Ratios | ||||||
| ROE | -18.0% | -33.3% | 7.4% | -44.4% | -28.4% | -40.5% |
| ROA | -13.3% | -21.7% | 5.1% | -22.7% | -14.2% | -20.0% |
| Net Profit Margin | -72.8% | -82.4% | 18.8% | -90.2% | -40.4% | -50.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Schrödinger, Inc. dividends
Schrödinger, Inc. has not paid dividends in the last 5 fiscal years.
Who owns Schrödinger, Inc.
- Insiders 2.99%
- Institutions 96.54%
- Public & others 0.47%
- Shares outstanding 65.6M
- Free float 57.6M
Schrödinger, Inc. company profile
- Company name
- Schrödinger, Inc.
- Ticker
- 43Z.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Information Services
- Employees
- 850
- Fiscal year end
- December
- Address
- 1540 Broadway, New York, NY, United States, 10036
- Phone
- 212 295 5800
- Website
- schrodinger.com
About Schrödinger, Inc.
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
Schrödinger, Inc. management
10- Dr. Ramy Farid Ph.D.CEO, President & Director · born 1965
- Dr. Karen Akinsanya Ph.D.President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships · born 1968
- Dr. Richard A. Friesner Ph.D.Co-Founder, Scientific Advisory Chairman and Director · born 1953
- Mr. Richie JainExecutive VP, CFO & Treasurer · born 1985
- Ms. Yvonne Tran Esq.Corporate Secretary, Chief Legal & People Officer · born 1971
- Prof. William Goddard III, Ph.D.Co-Founder & Scientific Advisor
- Mr. Kenneth Patrick LortonExecutive VP, CTO & COO of Software · born 1984
- Ms. Therese AbramsPrincipal Accounting Officer · born 1984
- Mr. Shane BraunerExecutive VP & Chief Information Officer · born 1977
- Ms. Jaren Irene MaddenChief Corporate Affairs Officer & Head of Investor Relations